Market revenue in 2023 | USD 715.4 million |
Market revenue in 2030 | USD 1,123.5 million |
Growth rate | 6.7% (CAGR from 2023 to 2030) |
Largest segment | Synthetic |
Fastest growing segment | Biotech |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Synthetic, Biotech |
Key market players worldwide | Basf SE, CordenPharma, Bristol-Myers Squibb Co, Pfizer Inc, Boehringer Ingelheim Pharma, Dr. Reddy’s Laboratories, Sun Pharmaceutical Industries, Albany Molecular Research, Sanofi SA, Lonza Group Ltd, Cipla Ltd DR, Merck & Co Inc, Teva Pharmaceutical Industries Ltd, Novartis AG ADR, Roche Holding AG |
Key Regions: U.S. , UK , Japan , Brazil , South Africa
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to high potency active pharmaceutical ingredients market will help companies and investors design strategic landscapes.
Synthetic was the largest segment with a revenue share of 73.4% in 2023. Horizon Databook has segmented the Middle East & Africa high potency active pharmaceutical ingredients market based on synthetic, biotech covering the revenue growth of each sub-segment from 2018 to 2030.
Rising economic development coupled with high unmet healthcare needs is fueling the growth of Middle East and Africa high potency active pharmaceutical ingredients market. This region includes South Africa and Saudi Arabia.
According to WHO, noncommunicable diseases and injuries account for 48% of the deaths in South Africa. The rate of diagnosis of cancer is low in the region. The delay in treatment and diagnosis leads to low survival rates. This creates an unmet need for low priced and economical tests in the region, which is expected to fuel the market growth.
Furthermore, Saudi Arabia reports 24,485 new cancer cases annually. According to JTO in 2019, lung cancer rate is growing in the region, which can be attributed to the fact that 46% of the population smokes daily. Various initiatives have been undertaken by the government to reduce the incidence of these diseases.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa high potency active pharmaceutical ingredients market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa high potency active pharmaceutical ingredients market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account